(Q37780253)

23 August 2017

1 reference

title

At the heart of tissue: endothelin system and end-organ damage (English)

1 reference

23 August 2017

Marc Iglarz

1

1 reference

23 August 2017

Martine Clozel

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

17 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

119

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

453-463

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 mRNA is widely expressed in porcine and human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Cellular distribution of endothelin-converting enzyme-1 in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Why are circulating concentrations of endothelin-1 so low?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Role of endothelin-1 in hypertension and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Role of endothelin in the increased vascular tone of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Tissue-dependent expression of matrix proteins in human endothelin-1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Increased sensitivity to acute and persistent pain in neuron-specific endothelin-1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Role of endothelin in fibrosis and anti-fibrotic potential of bosentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Regression of renal vascular fibrosis by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Survival with first-line bosentan in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Effects of long-term bosentan in children with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Localization of endothelin receptors in human uterus throughout the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Expression of the potent vasoconstrictor endothelin in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

Contribution of endogenous generation of endothelin-1 to basal vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100222

21 January 2018

Identifiers

DOI

10.1042/CS20100222

1 reference

23 August 2017

1 reference